stockrowIncyte Corporation (INCY) vs Insmed, Inc. (INSM)
- Incyte Corporation INCY 118.77 +0.64%
- Insmed, Inc. INSM 111.62 +2.63%
Incyte Corporation and Insmed, Inc. are both Biotechnology companies. Incyte Corporation and Insmed, Inc. are of similar size ($24.1B and $23.9B). Insmed, Inc. has negative trailing earnings, so its P/E is not meaningful; Incyte Corporation trades at 56.3×. Insmed, Inc. grew revenue faster over the last twelve months: 240.0% against 24.9%. Incyte Corporation has the higher net margin (6.71% vs −39.9%) and the higher return on invested capital (21.6% vs −247.6%). Across the 18 metrics below, Incyte Corporation leads on 16 and Insmed, Inc. on 2.
Valuation
Profitability
| Metric | INCY | INSM | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.69% | 84.40% | 65.16% |
| Operating margin | 10.42% | (37.11%) | 0.00% |
| Net margin | 6.71% | (39.85%) | 0.00% |
| Free cash flow margin | 11.31% | (41.30%) | 0.00% |
| Return on equity | 7.84% | (72.45%) | (50.12%) |
| Return on assets | 5.92% | (26.41%) | (45.60%) |
| Return on invested capital | 21.56% | (247.55%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack